Related Experiment Video

Updated: Jul 17, 2026

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Antithrombotic therapy for cervical artery dissection

S Engelter1, P Lyrer

  • 1Neurological Clinic and Stroke Unit, University Hospital Basel, Basel, Switzerland.

Frontiers of Neurology and Neuroscience
|February 10, 2007
PubMed

Insights

Antithrombotic therapy for cervical artery dissection (CAD) lacks evidence. Clinicians should tailor antiplatelet or anticoagulant choices based on individual patient factors until further research emerges.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Clinical Therapeutics

Background:

  • Antithrombotic therapy for cervical artery dissection (CAD) is currently based on empiric practices rather than robust evidence.
  • The optimal antithrombotic strategy for CAD patients remains undetermined, highlighting a significant gap in clinical guidelines.

Purpose of the Study:

  • To critically evaluate the existing pathophysiological arguments for and against anticoagulation versus antiplatelet therapy in cervical artery dissection.
  • To provide a framework for clinicians to make individualized treatment decisions in the absence of definitive evidence.

Main Methods:

  • Review and synthesis of pathophysiological data supporting or refuting the use of anticoagulants and antiplatelets in CAD.
  • Analysis of clinical and paraclinical features that may inform treatment selection.

Main Results:

  • No consensus exists on routine anticoagulation for all CAD patients.
  • Arguments for and against both anticoagulants and antiplatelets are presented, emphasizing the need for personalized approaches.

Conclusions:

  • A large-scale randomized controlled trial is needed but is a significant undertaking, suggesting a near-term lack of definitive answers.
  • Until further data are available, individualized treatment decisions based on patient-specific factors are recommended for antithrombotic therapy in CAD.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...